Analyze Diet
Australian veterinary journal2013; 91(5); 209-212; doi: 10.1111/avj.12039

Temporohyoid osteoarthropathy in two young horses.

Abstract: Two cases of temporohyoid osteoarthropathy (THO) in young Australian horses are described. The pathogenesis of THO is yet to be fully elucidated, but current theories include extension of infection from otitis media or interna to the temporohyoid joint or a primary but non-infectious degenerative condition within the temporohyoid joint. The young age of the horses and the unilateral distribution suggested an infectious aetiology. Both horses partially responded to treatment with broad-spectrum antimicrobial and anti-inflammatory drugs with concurrent management of ulcerative keratitis. The management of violent head shaking in one horse included the administration of gabapentin, an anticonvulsant known to have antihyperalgesic effects and reduce neuropathic pain.
Publication Date: 2013-03-11 PubMed ID: 23614517DOI: 10.1111/avj.12039Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research discusses two cases of temporohyoid osteoarthropathy (THO), a condition affecting the temporohyoid joint in horses, in young Australian horses. Treatment methods, including broad-spectrum anti-inflammatory and antimicrobial drugs alongside managing ulcerative keratitis, show partial success.

Understanding Temporohyoid Osteoarthropathy (THO)

  • Temporohyoid osteoarthropathy (THO) is a health condition in horses that involves joint degeneration.
  • The pathogenesis of THO—how it develops and progresses—is not yet completely understood.
  • Current theories for the cause of THO include the spread of an infection from otitis media (middle ear infection) or interna (inner ear infection) to the temporohyoid joint or non-infectious degenerative issues within the joint.

Case Studies and the Implication of Age

  • This research explores two cases of THO in young Australian horses.
  • The age of the horses and the unilateral (affecting one side) distribution pointed towards the cause being infectious, rather than non-infectious, in nature.

Treatment Techniques and Results

  • Both horses were treated with broad-spectrum antimicrobial and anti-inflammatory drugs.
  • The horses also had ulcerative keratitis—a corneal inflammation and ulceration—managed.
  • This course of treatment led to a partial response in both animals, indicating some success but not a complete cure.

Use of Anticonvulsant

  • One horse exhibited violent head shaking, a common symptom of THO.
  • This horse was administered gabapentin, an anticonvulsant drug with antihyperalgesic effects known to reduce neuropathic pain.

In conclusion, while treatment methods had some success, more comprehensive approaches and a deeper understanding of the development of THO can contribute to better management and potential eradication in future cases.

Cite This Article

APA
Readford PK, Lester GD, Secombe CJ. (2013). Temporohyoid osteoarthropathy in two young horses. Aust Vet J, 91(5), 209-212. https://doi.org/10.1111/avj.12039

Publication

ISSN: 1751-0813
NlmUniqueID: 0370616
Country: England
Language: English
Volume: 91
Issue: 5
Pages: 209-212

Researcher Affiliations

Readford, P K
  • The Equine Centre, School of Veterinary and Biomedical Sciences, Murdoch University, Western Australia, Australia.
Lester, G D
    Secombe, C J

      MeSH Terms

      • Amines / therapeutic use
      • Animals
      • Anticonvulsants / therapeutic use
      • Bone Diseases / diagnosis
      • Bone Diseases / drug therapy
      • Bone Diseases / microbiology
      • Bone Diseases / veterinary
      • Cyclohexanecarboxylic Acids / therapeutic use
      • Facial Nerve
      • Female
      • Gabapentin
      • Horse Diseases / diagnosis
      • Horse Diseases / drug therapy
      • Horse Diseases / microbiology
      • Horses
      • Paralysis / diagnosis
      • Paralysis / drug therapy
      • Paralysis / microbiology
      • Paralysis / veterinary
      • Temporal Bone / pathology
      • Treatment Outcome
      • gamma-Aminobutyric Acid / therapeutic use

      Citations

      This article has been cited 5 times.
      1. Lloyd-Edwards RA, Mulders E, Sloet van Oldruitenborgh-Oosterbaan MM, Veraa S. Computed Tomography of the Hyoid Apparatus in Equine Headshaking Syndrome. Vet Sci 2025 May 23;12(6).
        doi: 10.3390/vetsci12060511pubmed: 40559747google scholar: lookup
      2. Di Cesare F, Negro V, Ravasio G, Villa R, Draghi S, Cagnardi P. Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses. Animals (Basel) 2023 Jun 20;13(12).
        doi: 10.3390/ani13122045pubmed: 37370556google scholar: lookup
      3. Gold JR, Grubb TL, Cox S, Malavasi L, Villarino NL. Pharmacokinetics and pharmacodynamics of repeat dosing of gabapentin in adult horses. J Vet Intern Med 2022 Mar;36(2):792-797.
        doi: 10.1111/jvim.16386pubmed: 35150014google scholar: lookup
      4. Inui T, Yamada K, Itoh M, Yanagawa M, Higuchi T, Watanabe A, Imamura Y, Urabe M, Sasaki N. Computed tomography and magnetic resonance imaging findings for the initial stage of equine temporohyoid osteoarthropathy in a Thoroughbred foal. J Equine Sci 2017;28(3):117-121.
        doi: 10.1294/jes.28.117pubmed: 28955164google scholar: lookup
      5. Aleman M, Spriet M, Williams DC, Nieto JE. Neurologic Deficits Including Auditory Loss and Recovery of Function in Horses with Temporohyoid Osteoarthropathy. J Vet Intern Med 2016 Jan-Feb;30(1):282-8.
        doi: 10.1111/jvim.13654pubmed: 26513722google scholar: lookup